PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene Symbol | Gene ID | Gene Info |
---|---|---|
dlx1a
|
ENSDARG00000013125 | distal-less homeobox 1a |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
dlx1a | dr11_v1_chr9_+_3388099_3388099 | 0.01 | 9.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_-_12011390 | 20.04 |
ENSDART00000187403
|
si:dkey-202l22.6
|
si:dkey-202l22.6 |
chr15_-_46779934 | 15.67 |
ENSDART00000085136
|
clcn2c
|
chloride channel 2c |
chr15_-_12011202 | 13.11 |
ENSDART00000160427
ENSDART00000168715 |
si:dkey-202l22.6
|
si:dkey-202l22.6 |
chr5_+_56023186 | 10.36 |
ENSDART00000156230
|
fzd9a
|
frizzled class receptor 9a |
chr24_-_27452488 | 10.22 |
ENSDART00000136433
|
ccl34b.8
|
chemokine (C-C motif) ligand 34b, duplicate 8 |
chr4_+_73085993 | 10.11 |
ENSDART00000165749
|
si:ch73-170d6.2
|
si:ch73-170d6.2 |
chr12_+_22580579 | 9.62 |
ENSDART00000171725
ENSDART00000192290 |
capgb
|
capping protein (actin filament), gelsolin-like b |
chr22_-_30770751 | 9.44 |
ENSDART00000172115
|
AL831726.2
|
|
chr23_+_20110086 | 9.08 |
ENSDART00000054664
|
tnnc1b
|
troponin C type 1b (slow) |
chr22_+_19407531 | 8.73 |
ENSDART00000141060
|
si:dkey-78l4.2
|
si:dkey-78l4.2 |
chr14_-_4145594 | 8.70 |
ENSDART00000077348
|
casp3b
|
caspase 3, apoptosis-related cysteine peptidase b |
chr5_-_30615901 | 8.54 |
ENSDART00000147769
|
si:ch211-117m20.5
|
si:ch211-117m20.5 |
chr11_+_11504014 | 8.33 |
ENSDART00000104264
ENSDART00000134806 ENSDART00000132291 |
zgc:171226
|
zgc:171226 |
chr18_+_5490668 | 8.14 |
ENSDART00000167035
|
mibp2
|
muscle-specific beta 1 integrin binding protein 2 |
chr19_+_43297546 | 8.14 |
ENSDART00000168002
|
laptm5
|
lysosomal protein transmembrane 5 |
chr20_+_10538025 | 8.12 |
ENSDART00000129762
|
serpina1l
|
serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1, like |
chr5_-_42904329 | 8.12 |
ENSDART00000112807
|
cxcl20
|
chemokine (C-X-C motif) ligand 20 |
chr12_-_35830625 | 8.08 |
ENSDART00000180028
|
CU459056.1
|
|
chr19_-_5699703 | 8.04 |
ENSDART00000082050
|
zgc:174904
|
zgc:174904 |
chr6_+_39098397 | 7.87 |
ENSDART00000003716
ENSDART00000188655 |
prss60.2
|
protease, serine, 60.2 |
chr24_-_25166720 | 7.55 |
ENSDART00000141601
|
phldb2b
|
pleckstrin homology-like domain, family B, member 2b |
chr8_+_22516728 | 7.35 |
ENSDART00000146013
|
si:ch211-261n11.3
|
si:ch211-261n11.3 |
chr17_-_37395460 | 7.30 |
ENSDART00000148160
ENSDART00000075975 |
crip1
|
cysteine-rich protein 1 |
chr4_+_7391110 | 7.27 |
ENSDART00000160708
ENSDART00000187823 |
tnni4a
|
troponin I4a |
chr16_-_45094599 | 7.26 |
ENSDART00000155479
|
si:rp71-77l1.1
|
si:rp71-77l1.1 |
chr22_+_11775269 | 7.24 |
ENSDART00000140272
|
krt96
|
keratin 96 |
chr24_-_38110779 | 7.14 |
ENSDART00000147783
|
crp
|
c-reactive protein, pentraxin-related |
chr1_+_53842344 | 7.08 |
ENSDART00000114506
|
crfb17
|
cytokine receptor family member B17 |
chr16_+_23403602 | 7.08 |
ENSDART00000159848
|
s100w
|
S100 calcium binding protein W |
chr16_-_17713859 | 7.05 |
ENSDART00000149275
|
zgc:174935
|
zgc:174935 |
chr19_+_43780970 | 6.98 |
ENSDART00000063870
|
rpl11
|
ribosomal protein L11 |
chr4_-_9891874 | 6.92 |
ENSDART00000067193
|
adm2a
|
adrenomedullin 2a |
chr10_+_17776981 | 6.89 |
ENSDART00000141693
|
ccl19b
|
chemokine (C-C motif) ligand 19b |
chr18_-_977075 | 6.62 |
ENSDART00000032392
|
dhdhl
|
dihydrodiol dehydrogenase (dimeric), like |
chr10_+_42358426 | 6.60 |
ENSDART00000025691
|
dbnla
|
drebrin-like a |
chr1_+_52392511 | 6.54 |
ENSDART00000144025
|
si:ch211-217k17.8
|
si:ch211-217k17.8 |
chr20_-_5291012 | 6.52 |
ENSDART00000122892
|
cyp46a1.3
|
cytochrome P450, family 46, subfamily A, polypeptide 1, tandem duplicate 3 |
chr6_-_55399214 | 6.44 |
ENSDART00000168367
|
ctsa
|
cathepsin A |
chr16_+_23431189 | 6.44 |
ENSDART00000004679
|
icn
|
ictacalcin |
chr16_-_51271962 | 6.40 |
ENSDART00000164021
ENSDART00000046420 |
serpinb1l1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1 |
chr16_+_35916371 | 6.39 |
ENSDART00000167208
|
sh3d21
|
SH3 domain containing 21 |
chr15_-_21877726 | 6.24 |
ENSDART00000127819
ENSDART00000145646 ENSDART00000100897 ENSDART00000144739 |
zgc:162608
|
zgc:162608 |
chr20_+_36812368 | 6.24 |
ENSDART00000062931
|
abracl
|
ABRA C-terminal like |
chr12_-_4532066 | 6.22 |
ENSDART00000092687
|
trpm4b.2
|
transient receptor potential cation channel, subfamily M, member 4b, transient receptor potential cation channel, subfamily M, member 4b, tandem duplicate 2 |
chr10_-_22095505 | 6.15 |
ENSDART00000140210
|
ponzr10
|
plac8 onzin related protein 10 |
chr6_+_28752943 | 6.14 |
ENSDART00000078447
ENSDART00000146574 |
tprg1
|
tumor protein p63 regulated 1 |
chr20_+_38279523 | 6.13 |
ENSDART00000061311
|
ccl38a.5
|
chemokine (C-C motif) ligand 38, duplicate 5 |
chr20_+_10544100 | 6.12 |
ENSDART00000113927
|
serpina1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr25_+_13620555 | 6.07 |
ENSDART00000163642
|
si:ch211-172l8.4
|
si:ch211-172l8.4 |
chr7_+_6652967 | 6.02 |
ENSDART00000102681
|
pnp5a
|
purine nucleoside phosphorylase 5a |
chr1_-_58573646 | 6.00 |
ENSDART00000167777
|
adgre5b.3
|
adhesion G protein-coupled receptor E5b, duplicate 3 |
chr20_-_26822522 | 5.98 |
ENSDART00000146326
ENSDART00000046764 ENSDART00000103234 ENSDART00000143267 |
gmds
|
GDP-mannose 4,6-dehydratase |
chr3_-_40973791 | 5.98 |
ENSDART00000136174
|
cyp3c1
|
cytochrome P450, family 3, subfamily c, polypeptide 1 |
chr13_+_33688474 | 5.96 |
ENSDART00000161465
|
CABZ01087953.1
|
|
chr15_-_47848544 | 5.96 |
ENSDART00000098711
|
eif3k
|
eukaryotic translation initiation factor 3, subunit K |
chr24_+_19415124 | 5.95 |
ENSDART00000186931
|
sulf1
|
sulfatase 1 |
chr25_+_31227747 | 5.88 |
ENSDART00000033872
|
tnni2a.1
|
troponin I type 2a (skeletal, fast), tandem duplicate 1 |
chr5_-_55981288 | 5.88 |
ENSDART00000146616
|
si:dkey-189h5.6
|
si:dkey-189h5.6 |
chr22_-_10121880 | 5.81 |
ENSDART00000002348
|
rdh5
|
retinol dehydrogenase 5 (11-cis/9-cis) |
chr23_-_5719453 | 5.80 |
ENSDART00000033093
|
lad1
|
ladinin |
chr21_-_5205617 | 5.73 |
ENSDART00000145554
ENSDART00000045284 |
rpl37
|
ribosomal protein L37 |
chr2_+_36112273 | 5.71 |
ENSDART00000191315
|
traj35
|
T-cell receptor alpha joining 35 |
chr18_+_8912710 | 5.67 |
ENSDART00000142866
|
tmem243a
|
transmembrane protein 243, mitochondrial a |
chr16_+_23404170 | 5.66 |
ENSDART00000170061
|
s100w
|
S100 calcium binding protein W |
chr19_-_5372572 | 5.64 |
ENSDART00000151326
|
krt17
|
keratin 17 |
chr18_-_48550426 | 5.59 |
ENSDART00000145189
|
kcnj1a.1
|
potassium inwardly-rectifying channel, subfamily J, member 1a, tandem duplicate 1 |
chr13_+_25397098 | 5.54 |
ENSDART00000132953
|
gsto2
|
glutathione S-transferase omega 2 |
chr24_-_34680956 | 5.42 |
ENSDART00000171009
|
ctnna1
|
catenin (cadherin-associated protein), alpha 1 |
chr1_-_18615063 | 5.41 |
ENSDART00000014916
|
klf3
|
Kruppel-like factor 3 (basic) |
chr8_-_31107537 | 5.40 |
ENSDART00000098925
|
vgll4l
|
vestigial like 4 like |
chr25_+_10410620 | 5.31 |
ENSDART00000151886
|
ehf
|
ets homologous factor |
chr13_+_25396896 | 5.30 |
ENSDART00000041257
|
gsto2
|
glutathione S-transferase omega 2 |
chr10_-_20445549 | 5.28 |
ENSDART00000064613
|
loxl2a
|
lysyl oxidase-like 2a |
chr16_-_20312146 | 5.28 |
ENSDART00000134980
|
si:dkeyp-86h10.3
|
si:dkeyp-86h10.3 |
chr6_-_40842768 | 5.27 |
ENSDART00000076160
|
mustn1a
|
musculoskeletal, embryonic nuclear protein 1a |
chr18_+_3037998 | 5.25 |
ENSDART00000185844
ENSDART00000162657 |
rps3
|
ribosomal protein S3 |
chr17_+_16046314 | 5.24 |
ENSDART00000154554
ENSDART00000154338 ENSDART00000155336 |
si:ch73-204p21.2
|
si:ch73-204p21.2 |
chr9_-_9415000 | 5.24 |
ENSDART00000146210
|
si:ch211-214p13.9
|
si:ch211-214p13.9 |
chr8_-_27656765 | 5.14 |
ENSDART00000078491
|
mov10b.2
|
Moloney leukemia virus 10b, tandem duplicate 2 |
chr20_-_33976305 | 5.12 |
ENSDART00000111022
|
sele
|
selectin E |
chr23_-_24394719 | 5.12 |
ENSDART00000044918
|
epha2b
|
eph receptor A2 b |
chr21_+_11244068 | 5.11 |
ENSDART00000163432
|
arid6
|
AT-rich interaction domain 6 |
chr22_-_10541712 | 5.09 |
ENSDART00000013933
|
si:dkey-42i9.4
|
si:dkey-42i9.4 |
chr5_+_19343880 | 5.09 |
ENSDART00000148130
|
acacb
|
acetyl-CoA carboxylase beta |
chr3_+_32492467 | 5.04 |
ENSDART00000151329
|
trpm4a
|
transient receptor potential cation channel, subfamily M, member 4a |
chr8_-_23612462 | 5.03 |
ENSDART00000025024
|
slc38a5b
|
solute carrier family 38, member 5b |
chr23_-_29569827 | 5.03 |
ENSDART00000078300
ENSDART00000133576 ENSDART00000158349 |
nmnat1-rbp7a
nmnat1
|
nmnat1-rbp7a readthrough nicotinamide nucleotide adenylyltransferase 1 |
chr10_+_8690936 | 5.02 |
ENSDART00000144218
|
si:dkey-27b3.4
|
si:dkey-27b3.4 |
chr25_-_23526058 | 5.02 |
ENSDART00000191331
ENSDART00000062930 |
phlda2
|
pleckstrin homology-like domain, family A, member 2 |
chr19_-_5669122 | 4.98 |
ENSDART00000112211
|
si:ch211-264f5.2
|
si:ch211-264f5.2 |
chr23_+_4709607 | 4.97 |
ENSDART00000166503
ENSDART00000158752 ENSDART00000163860 ENSDART00000172739 |
raf1a
raf1a
|
Raf-1 proto-oncogene, serine/threonine kinase a Raf-1 proto-oncogene, serine/threonine kinase a |
chr22_+_16308450 | 4.97 |
ENSDART00000105678
|
lrrc39
|
leucine rich repeat containing 39 |
chr6_-_7720332 | 4.97 |
ENSDART00000135945
|
rpsa
|
ribosomal protein SA |
chr19_+_41464870 | 4.94 |
ENSDART00000102778
|
dlx6a
|
distal-less homeobox 6a |
chr18_-_48547564 | 4.93 |
ENSDART00000138607
|
kcnj1a.1
|
potassium inwardly-rectifying channel, subfamily J, member 1a, tandem duplicate 1 |
chr1_+_45056371 | 4.90 |
ENSDART00000073689
ENSDART00000167309 |
btr01
|
bloodthirsty-related gene family, member 1 |
chr21_+_43702016 | 4.90 |
ENSDART00000017176
|
dkc1
|
dyskeratosis congenita 1, dyskerin |
chr20_-_8094718 | 4.89 |
ENSDART00000122902
|
si:ch211-232i5.3
|
si:ch211-232i5.3 |
chr25_-_21031007 | 4.87 |
ENSDART00000138985
|
gnaia
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide a |
chr20_-_49704915 | 4.86 |
ENSDART00000189232
|
COX7A2 (1 of many)
|
cytochrome c oxidase subunit 7A2 |
chr1_-_23308225 | 4.84 |
ENSDART00000137567
ENSDART00000008201 |
smim14
|
small integral membrane protein 14 |
chr16_+_23975930 | 4.83 |
ENSDART00000147858
ENSDART00000144347 ENSDART00000115270 |
apoc4
|
apolipoprotein C-IV |
chr12_+_13319132 | 4.72 |
ENSDART00000049167
|
psme2
|
proteasome activator subunit 2 |
chr19_-_7690975 | 4.72 |
ENSDART00000151384
|
si:dkey-204a24.10
|
si:dkey-204a24.10 |
chr17_+_16046132 | 4.69 |
ENSDART00000155005
|
si:ch73-204p21.2
|
si:ch73-204p21.2 |
chr9_-_712308 | 4.65 |
ENSDART00000144625
|
ndufb3
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3 |
chr12_-_48188928 | 4.64 |
ENSDART00000184384
|
pald1a
|
phosphatase domain containing, paladin 1a |
chr21_+_19635486 | 4.61 |
ENSDART00000185736
|
fgf10a
|
fibroblast growth factor 10a |
chr15_-_43625549 | 4.61 |
ENSDART00000168589
|
ctsc
|
cathepsin C |
chr19_+_2590182 | 4.60 |
ENSDART00000162293
|
si:ch73-345f18.3
|
si:ch73-345f18.3 |
chr12_-_46176115 | 4.55 |
ENSDART00000152848
|
si:ch211-226h7.8
|
si:ch211-226h7.8 |
chr21_-_39024754 | 4.54 |
ENSDART00000056878
|
traf4b
|
tnf receptor-associated factor 4b |
chr21_-_20932603 | 4.54 |
ENSDART00000138155
ENSDART00000079709 |
c6
|
complement component 6 |
chr16_+_23799622 | 4.49 |
ENSDART00000046922
|
rab13
|
RAB13, member RAS oncogene family |
chr22_-_16154771 | 4.48 |
ENSDART00000009464
|
slc30a7
|
solute carrier family 30 (zinc transporter), member 7 |
chr13_+_7442023 | 4.47 |
ENSDART00000080975
|
tnfaip2b
|
tumor necrosis factor, alpha-induced protein 2b |
chr23_+_4689626 | 4.43 |
ENSDART00000131532
|
gp9
|
glycoprotein IX (platelet) |
chr9_+_30421489 | 4.41 |
ENSDART00000145025
ENSDART00000132058 |
zgc:113314
|
zgc:113314 |
chr18_+_26422124 | 4.40 |
ENSDART00000060245
|
ctsh
|
cathepsin H |
chr4_-_77218637 | 4.39 |
ENSDART00000174325
|
psmb10
|
proteasome subunit beta 10 |
chr23_-_33350990 | 4.38 |
ENSDART00000144831
|
si:ch211-226m16.2
|
si:ch211-226m16.2 |
chr8_-_36287046 | 4.36 |
ENSDART00000162877
|
si:busm1-194e12.11
|
si:busm1-194e12.11 |
chr5_+_6672870 | 4.35 |
ENSDART00000126598
|
pxna
|
paxillin a |
chr3_-_18744511 | 4.34 |
ENSDART00000145539
|
zgc:113333
|
zgc:113333 |
chr17_+_24851951 | 4.29 |
ENSDART00000180746
|
cx35.4
|
connexin 35.4 |
chr12_-_25294096 | 4.28 |
ENSDART00000183398
|
hcar1-4
|
hydroxycarboxylic acid receptor 1-4 |
chr10_+_29840725 | 4.24 |
ENSDART00000127268
|
BX120005.1
|
|
chr19_+_823945 | 4.20 |
ENSDART00000142287
|
ppp1r18
|
protein phosphatase 1, regulatory subunit 18 |
chr13_-_31008275 | 4.17 |
ENSDART00000139394
|
wdfy4
|
WDFY family member 4 |
chr6_+_24398907 | 4.17 |
ENSDART00000167482
|
tgfbr3
|
transforming growth factor, beta receptor III |
chr4_-_17669881 | 4.12 |
ENSDART00000066997
|
dram1
|
DNA-damage regulated autophagy modulator 1 |
chr2_+_40181633 | 4.11 |
ENSDART00000185494
|
FP236331.1
|
|
chr16_+_42471455 | 4.10 |
ENSDART00000166640
|
si:ch211-215k15.5
|
si:ch211-215k15.5 |
chr15_-_33965440 | 4.10 |
ENSDART00000163841
|
lsr
|
lipolysis stimulated lipoprotein receptor |
chr5_+_27897504 | 4.10 |
ENSDART00000130936
|
adam28
|
ADAM metallopeptidase domain 28 |
chr14_-_33481428 | 4.06 |
ENSDART00000147059
ENSDART00000140001 ENSDART00000124242 ENSDART00000164836 ENSDART00000190104 ENSDART00000186833 ENSDART00000180873 |
lamp2
|
lysosomal-associated membrane protein 2 |
chr21_-_44081540 | 4.00 |
ENSDART00000130833
|
FO704810.1
|
|
chr5_+_27898226 | 3.95 |
ENSDART00000098604
ENSDART00000180251 |
adam28
|
ADAM metallopeptidase domain 28 |
chr22_+_16308806 | 3.94 |
ENSDART00000162685
|
lrrc39
|
leucine rich repeat containing 39 |
chr23_+_39695827 | 3.94 |
ENSDART00000113893
ENSDART00000186679 |
tmco4
|
transmembrane and coiled-coil domains 4 |
chr21_+_25236297 | 3.94 |
ENSDART00000112783
|
tmem45b
|
transmembrane protein 45B |
chr13_-_330004 | 3.94 |
ENSDART00000093149
|
ddx21
|
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
chr10_+_21867307 | 3.91 |
ENSDART00000126629
|
cbln17
|
cerebellin 17 |
chr11_-_44194132 | 3.91 |
ENSDART00000182954
ENSDART00000111271 |
CABZ01080074.1
|
|
chr11_+_37250839 | 3.89 |
ENSDART00000170209
|
il17rc
|
interleukin 17 receptor C |
chr6_+_41191482 | 3.88 |
ENSDART00000000877
|
opn1mw3
|
opsin 1 (cone pigments), medium-wave-sensitive, 3 |
chr11_-_11890001 | 3.87 |
ENSDART00000081544
|
wipf2a
|
WAS/WASL interacting protein family, member 2a |
chr22_-_1079773 | 3.87 |
ENSDART00000136668
|
si:ch1073-15f12.3
|
si:ch1073-15f12.3 |
chr4_+_16715267 | 3.85 |
ENSDART00000143849
|
pkp2
|
plakophilin 2 |
chr13_+_646700 | 3.80 |
ENSDART00000006892
|
tp53bp2a
|
tumor protein p53 binding protein, 2a |
chr16_-_12688957 | 3.80 |
ENSDART00000147854
ENSDART00000184587 |
mfap5
|
microfibril associated protein 5 |
chr1_-_37377509 | 3.73 |
ENSDART00000113542
|
tnip2
|
TNFAIP3 interacting protein 2 |
chr23_-_1017605 | 3.69 |
ENSDART00000138290
|
cdh26.1
|
cadherin 26, tandem duplicate 1 |
chr12_-_26538823 | 3.68 |
ENSDART00000143213
|
acsf2
|
acyl-CoA synthetase family member 2 |
chr11_+_1602916 | 3.67 |
ENSDART00000184434
ENSDART00000112597 ENSDART00000192165 |
si:dkey-40c23.2
si:dkey-40c23.3
|
si:dkey-40c23.2 si:dkey-40c23.3 |
chr17_-_38291065 | 3.67 |
ENSDART00000152056
|
pax9
|
paired box 9 |
chr16_-_21810668 | 3.66 |
ENSDART00000156575
|
dicp3.3
|
diverse immunoglobulin domain-containing protein 3.3 |
chr1_-_9195629 | 3.65 |
ENSDART00000143587
ENSDART00000192174 |
ern2
|
endoplasmic reticulum to nucleus signaling 2 |
chr5_+_27404946 | 3.65 |
ENSDART00000121886
ENSDART00000005025 |
hdr
|
hematopoietic death receptor |
chr21_-_11654422 | 3.64 |
ENSDART00000081614
ENSDART00000132699 |
cast
|
calpastatin |
chr2_+_52232630 | 3.64 |
ENSDART00000006216
|
plpp2a
|
phospholipid phosphatase 2a |
chr18_+_8912536 | 3.63 |
ENSDART00000134827
ENSDART00000061904 |
tmem243a
|
transmembrane protein 243, mitochondrial a |
chr3_-_25268751 | 3.61 |
ENSDART00000139423
|
mgat3a
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase a |
chr20_-_40755614 | 3.61 |
ENSDART00000061247
|
cx32.3
|
connexin 32.3 |
chr10_-_13343831 | 3.58 |
ENSDART00000135941
|
il11ra
|
interleukin 11 receptor, alpha |
chr17_-_20118145 | 3.57 |
ENSDART00000149737
ENSDART00000165606 |
ryr2b
|
ryanodine receptor 2b (cardiac) |
chr17_-_32413147 | 3.56 |
ENSDART00000149102
|
grhl1
|
grainyhead-like transcription factor 1 |
chr3_+_27798094 | 3.55 |
ENSDART00000075100
ENSDART00000151437 |
carhsp1
|
calcium regulated heat stable protein 1 |
chr21_-_32060993 | 3.54 |
ENSDART00000131651
|
si:ch211-160j14.2
|
si:ch211-160j14.2 |
chr16_+_23976227 | 3.54 |
ENSDART00000193013
|
apoc4
|
apolipoprotein C-IV |
chr24_+_21621654 | 3.54 |
ENSDART00000002595
|
rpl21
|
ribosomal protein L21 |
chr4_+_77709678 | 3.54 |
ENSDART00000036856
|
AL935186.1
|
|
chr19_-_340347 | 3.52 |
ENSDART00000139924
|
golph3l
|
golgi phosphoprotein 3-like |
chr7_-_13648635 | 3.52 |
ENSDART00000148957
ENSDART00000130967 |
spg21
|
spastic paraplegia 21 (autosomal recessive, Mast syndrome) |
chr4_+_6032640 | 3.52 |
ENSDART00000157487
|
tfec
|
transcription factor EC |
chr11_-_6877973 | 3.51 |
ENSDART00000160271
|
ddx49
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49 |
chr16_-_26676685 | 3.51 |
ENSDART00000103431
|
esrp1
|
epithelial splicing regulatory protein 1 |
chr19_+_770300 | 3.50 |
ENSDART00000062518
|
gstr
|
glutathione S-transferase rho |
chr2_-_23768818 | 3.50 |
ENSDART00000148685
ENSDART00000191167 |
xirp1
|
xin actin binding repeat containing 1 |
chr1_+_58922027 | 3.48 |
ENSDART00000159479
|
trip10b
|
thyroid hormone receptor interactor 10b |
chr18_+_8912113 | 3.48 |
ENSDART00000147467
|
tmem243a
|
transmembrane protein 243, mitochondrial a |
chr6_+_12922002 | 3.48 |
ENSDART00000080350
ENSDART00000149018 |
cxcr4a
|
chemokine (C-X-C motif) receptor 4a |
chr24_-_32582880 | 3.47 |
ENSDART00000186307
|
rdh12l
|
retinol dehydrogenase 12, like |
chr13_+_35339182 | 3.46 |
ENSDART00000019323
|
jag1b
|
jagged 1b |
chr10_+_17714866 | 3.44 |
ENSDART00000039969
|
slc20a1b
|
solute carrier family 20 (phosphate transporter), member 1b |
chr23_+_19813677 | 3.42 |
ENSDART00000139192
ENSDART00000142308 |
emd
|
emerin (Emery-Dreifuss muscular dystrophy) |
chr9_+_41156818 | 3.41 |
ENSDART00000105764
ENSDART00000147052 |
stat4
|
signal transducer and activator of transcription 4 |
chr17_-_7733037 | 3.41 |
ENSDART00000064657
|
stx11a
|
syntaxin 11a |
chr5_-_38777852 | 3.40 |
ENSDART00000131603
|
si:dkey-58f10.4
|
si:dkey-58f10.4 |
chr11_+_40812590 | 3.40 |
ENSDART00000186690
|
errfi1a
|
ERBB receptor feedback inhibitor 1a |
chr11_+_705727 | 3.40 |
ENSDART00000165366
|
timp4.2
|
TIMP metallopeptidase inhibitor 4, tandem duplicate 2 |
chr22_-_10158038 | 3.39 |
ENSDART00000047444
|
rbck1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr6_-_43283122 | 3.38 |
ENSDART00000186022
|
frmd4ba
|
FERM domain containing 4Ba |
chr3_-_29899172 | 3.38 |
ENSDART00000140518
ENSDART00000020311 |
rpl27
|
ribosomal protein L27 |
chr7_+_8361083 | 3.37 |
ENSDART00000102091
|
jac7
|
jacalin 7 |
chr20_+_35484070 | 3.35 |
ENSDART00000026234
ENSDART00000141675 |
mep1a.2
|
meprin A, alpha (PABA peptide hydrolase), tandem duplicate 2 |
chr9_+_41080029 | 3.32 |
ENSDART00000141179
ENSDART00000019289 |
zgc:136439
|
zgc:136439 |
chr4_+_70151160 | 3.31 |
ENSDART00000111816
|
si:dkey-3h2.4
|
si:dkey-3h2.4 |
chr25_+_3104959 | 3.31 |
ENSDART00000167130
|
rab3il1
|
RAB3A interacting protein (rabin3)-like 1 |
chr11_-_7380674 | 3.31 |
ENSDART00000014979
ENSDART00000103418 |
vtg3
|
vitellogenin 3, phosvitinless |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.3 | GO:0002369 | T cell cytokine production(GO:0002369) |
2.4 | 7.3 | GO:0097237 | cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
1.6 | 4.9 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
1.6 | 6.5 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.5 | 6.0 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 5.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.3 | 6.6 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
1.3 | 5.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
1.3 | 5.0 | GO:1902024 | L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
1.2 | 6.2 | GO:0010873 | regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) |
1.2 | 3.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) toll-like receptor 3 signaling pathway(GO:0034138) |
1.2 | 3.7 | GO:0032677 | interleukin-8 production(GO:0032637) regulation of interleukin-8 production(GO:0032677) positive regulation of interleukin-8 production(GO:0032757) |
1.2 | 4.6 | GO:0061033 | lung growth(GO:0060437) secretion by lung epithelial cell involved in lung growth(GO:0061033) |
1.1 | 4.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.1 | 6.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.1 | 4.5 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
1.1 | 2.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) protein-lipid complex assembly(GO:0065005) |
1.1 | 5.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.0 | 5.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.0 | 15.7 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
1.0 | 2.9 | GO:1902893 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
1.0 | 5.8 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.9 | 2.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.9 | 6.8 | GO:2000290 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) regulation of myotome development(GO:2000290) |
0.8 | 2.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 3.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.8 | 5.7 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.8 | 5.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.8 | 2.4 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.7 | 2.9 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.7 | 3.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.7 | 2.9 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.7 | 2.8 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.7 | 3.5 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.7 | 7.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.7 | 2.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.7 | 3.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.7 | 2.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 2.0 | GO:0060923 | negative regulation of striated muscle cell differentiation(GO:0051154) negative regulation of cardiac muscle tissue development(GO:0055026) cardiac muscle cell fate commitment(GO:0060923) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901296) negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.6 | 4.3 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 3.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.6 | 3.0 | GO:0010693 | regulation of alkaline phosphatase activity(GO:0010692) negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 5.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.6 | 3.4 | GO:0000455 | enzyme-directed rRNA pseudouridine synthesis(GO:0000455) |
0.6 | 3.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 1.7 | GO:0006589 | octopamine biosynthetic process(GO:0006589) dopamine catabolic process(GO:0042420) norepinephrine biosynthetic process(GO:0042421) octopamine metabolic process(GO:0046333) |
0.5 | 3.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.5 | 2.7 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.5 | 16.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.5 | 2.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.5 | 2.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 2.1 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 2.6 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.5 | 2.0 | GO:0003242 | growth involved in heart morphogenesis(GO:0003241) cardiac chamber ballooning(GO:0003242) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.5 | 3.0 | GO:0097241 | hematopoietic stem cell migration to bone marrow(GO:0097241) |
0.5 | 2.0 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.5 | 2.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 1.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.5 | 1.9 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.5 | 24.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.5 | 1.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.5 | 2.3 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.4 | 9.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 4.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 2.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.4 | 25.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.4 | 6.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 2.6 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.4 | 2.5 | GO:0097250 | mitochondrial respiratory chain supercomplex assembly(GO:0097250) |
0.4 | 2.1 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.4 | 1.6 | GO:0014743 | regulation of muscle hypertrophy(GO:0014743) |
0.4 | 4.3 | GO:0006032 | chitin catabolic process(GO:0006032) |
0.4 | 7.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.4 | 4.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.4 | 2.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.4 | 1.1 | GO:1904478 | regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.4 | 1.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 5.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 26.2 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.4 | 8.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 6.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 3.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 1.7 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.3 | 1.3 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.3 | 1.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 4.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 1.3 | GO:0070131 | regulation of mitochondrial translation(GO:0070129) positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 1.6 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.3 | 1.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 2.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.6 | GO:1902804 | negative regulation of neurotransmitter secretion(GO:0046929) response to cAMP(GO:0051591) cellular response to cAMP(GO:0071320) negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 4.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 6.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 1.5 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.3 | 2.1 | GO:1902315 | cell cycle DNA replication initiation(GO:1902292) nuclear cell cycle DNA replication initiation(GO:1902315) mitotic DNA replication initiation(GO:1902975) |
0.3 | 8.0 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
0.3 | 3.2 | GO:0018120 | peptidyl-arginine ADP-ribosylation(GO:0018120) |
0.3 | 2.6 | GO:0046341 | CDP-diacylglycerol biosynthetic process(GO:0016024) CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 2.9 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 1.4 | GO:0010867 | regulation of triglyceride biosynthetic process(GO:0010866) positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 2.0 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.3 | 0.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 10.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.3 | 1.1 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.1 | GO:0055107 | Golgi to secretory granule transport(GO:0055107) |
0.3 | 0.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.3 | 2.7 | GO:0031579 | membrane raft assembly(GO:0001765) membrane raft organization(GO:0031579) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.3 | 2.6 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.3 | 1.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 5.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.3 | 4.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 1.7 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.2 | 3.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 1.0 | GO:1900060 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.2 | 1.7 | GO:0040016 | embryonic cleavage(GO:0040016) positive regulation of myoblast fusion(GO:1901741) |
0.2 | 4.8 | GO:2001235 | positive regulation of apoptotic signaling pathway(GO:2001235) |
0.2 | 1.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.7 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 7.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 5.4 | GO:0035141 | medial fin morphogenesis(GO:0035141) |
0.2 | 0.7 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.2 | 1.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 2.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 3.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 1.3 | GO:0097065 | anterior head development(GO:0097065) |
0.2 | 2.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.2 | 0.8 | GO:1904357 | negative regulation of telomere maintenance via telomerase(GO:0032211) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.2 | 4.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) regulation of oxygen metabolic process(GO:2000374) positive regulation of oxygen metabolic process(GO:2000376) |
0.2 | 0.6 | GO:0097435 | fibril organization(GO:0097435) |
0.2 | 5.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 2.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 6.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 10.9 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 1.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 1.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 1.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 1.1 | GO:0097101 | blood vessel endothelial cell fate specification(GO:0097101) |
0.2 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) GMP metabolic process(GO:0046037) |
0.2 | 1.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 3.7 | GO:0070672 | interleukin-15-mediated signaling pathway(GO:0035723) response to interleukin-15(GO:0070672) cellular response to interleukin-15(GO:0071350) |
0.2 | 10.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.2 | 0.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 3.4 | GO:0060021 | palate development(GO:0060021) |
0.2 | 0.9 | GO:0007344 | karyogamy(GO:0000741) pronuclear fusion(GO:0007344) |
0.2 | 2.8 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.2 | 1.0 | GO:0032447 | tRNA wobble position uridine thiolation(GO:0002143) protein urmylation(GO:0032447) |
0.2 | 1.0 | GO:1905066 | regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.2 | 3.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 2.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 1.8 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 2.8 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 1.6 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 4.5 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 4.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.9 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 8.8 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.2 | 2.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 5.0 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.3 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 5.2 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 1.0 | GO:1990511 | piRNA biosynthetic process(GO:1990511) |
0.1 | 8.6 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 1.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 1.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 1.1 | GO:0021588 | cerebellum formation(GO:0021588) |
0.1 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 1.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.1 | 1.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 3.7 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 1.1 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 2.0 | GO:0090481 | pyrimidine nucleotide-sugar transport(GO:0015781) pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 2.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 3.3 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.7 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.5 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 0.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 1.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 2.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.9 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 1.0 | GO:0046247 | carotene metabolic process(GO:0016119) carotene catabolic process(GO:0016121) terpene metabolic process(GO:0042214) terpene catabolic process(GO:0046247) |
0.1 | 1.1 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) purinergic receptor signaling pathway(GO:0035587) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 5.3 | GO:0050673 | epithelial cell proliferation(GO:0050673) |
0.1 | 0.6 | GO:0046931 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.1 | 1.2 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.1 | 0.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 1.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 2.8 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 1.2 | GO:0001840 | neural plate development(GO:0001840) |
0.1 | 3.8 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.1 | 0.9 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.2 | GO:0031111 | negative regulation of microtubule depolymerization(GO:0007026) negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 0.2 | GO:0051055 | negative regulation of lipid biosynthetic process(GO:0051055) |
0.1 | 1.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.9 | GO:0060004 | reflex(GO:0060004) vestibular reflex(GO:0060005) |
0.1 | 0.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 1.0 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.3 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.1 | 1.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 6.2 | GO:1990266 | neutrophil migration(GO:1990266) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 1.6 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.6 | GO:0036372 | opsin transport(GO:0036372) |
0.1 | 2.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.4 | GO:1903076 | regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.1 | 1.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 5.0 | GO:0001666 | response to hypoxia(GO:0001666) |
0.1 | 0.9 | GO:0042531 | tyrosine phosphorylation of STAT protein(GO:0007260) regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 1.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 1.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 3.1 | GO:0017144 | drug metabolic process(GO:0017144) drug catabolic process(GO:0042737) exogenous drug catabolic process(GO:0042738) |
0.1 | 2.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 2.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 1.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 5.1 | GO:0031101 | fin regeneration(GO:0031101) |
0.1 | 1.1 | GO:0045841 | mitotic spindle assembly checkpoint(GO:0007094) spindle checkpoint(GO:0031577) negative regulation of mitotic metaphase/anaphase transition(GO:0045841) spindle assembly checkpoint(GO:0071173) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) |
0.1 | 1.9 | GO:0050821 | protein stabilization(GO:0050821) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 2.7 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.1 | 1.5 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 7.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 4.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 6.8 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.0 | 2.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.3 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 1.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 2.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 3.1 | GO:0048545 | response to steroid hormone(GO:0048545) |
0.0 | 0.1 | GO:1903726 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of lipid kinase activity(GO:0090219) negative regulation of phospholipid metabolic process(GO:1903726) |
0.0 | 12.8 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.0 | 0.8 | GO:0060046 | binding of sperm to zona pellucida(GO:0007339) egg coat formation(GO:0035803) regulation of acrosome reaction(GO:0060046) positive regulation of acrosome reaction(GO:2000344) |
0.0 | 2.0 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.0 | 2.2 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
0.0 | 1.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 3.5 | GO:0031497 | nucleosome assembly(GO:0006334) chromatin assembly(GO:0031497) |
0.0 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.3 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.0 | 2.4 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 3.6 | GO:0001756 | somitogenesis(GO:0001756) |
0.0 | 0.2 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.0 | 1.4 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 1.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 1.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 1.3 | GO:0032147 | activation of protein kinase activity(GO:0032147) |
0.0 | 2.0 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.4 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 2.6 | GO:0001894 | tissue homeostasis(GO:0001894) |
0.0 | 0.6 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.0 | 0.8 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 2.1 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 3.3 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.2 | GO:0036268 | swimming(GO:0036268) |
0.0 | 0.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 1.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 1.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 1.3 | GO:0043065 | positive regulation of cell death(GO:0010942) positive regulation of apoptotic process(GO:0043065) positive regulation of programmed cell death(GO:0043068) |
0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.9 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 1.3 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.0 | 0.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.3 | GO:0036368 | cone photoresponse recovery(GO:0036368) |
0.0 | 0.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.0 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 1.0 | GO:1901215 | negative regulation of neuron death(GO:1901215) |
0.0 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.6 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 2.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.7 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.0 | 3.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 2.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 1.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.5 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 26.7 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 2.9 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.9 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) myelination(GO:0042552) |
0.0 | 0.3 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 1.0 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.7 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.6 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) erythrocyte homeostasis(GO:0034101) |
0.0 | 0.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.5 | GO:0061515 | myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:1900052 | regulation of isoprenoid metabolic process(GO:0019747) regulation of vitamin metabolic process(GO:0030656) regulation of hormone metabolic process(GO:0032350) regulation of retinoic acid biosynthetic process(GO:1900052) |
0.0 | 0.5 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.0 | 1.3 | GO:0060026 | convergent extension(GO:0060026) |
0.0 | 0.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.5 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 0.4 | GO:0050708 | regulation of protein secretion(GO:0050708) |
0.0 | 0.1 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.1 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
1.3 | 5.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.2 | 4.9 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
1.2 | 3.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.2 | 4.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.1 | 3.4 | GO:0098556 | cytoplasmic side of rough endoplasmic reticulum membrane(GO:0098556) |
1.0 | 3.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.9 | 3.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.8 | 3.3 | GO:0070319 | Golgi to plasma membrane transport vesicle(GO:0070319) |
0.7 | 2.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.6 | 8.4 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 25.3 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 2.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 2.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 2.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 6.6 | GO:0002102 | podosome(GO:0002102) |
0.4 | 8.8 | GO:0031430 | M band(GO:0031430) |
0.4 | 2.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 3.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 3.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 2.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 2.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 4.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 3.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 7.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 8.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 1.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 4.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 13.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 0.8 | GO:1990879 | CST complex(GO:1990879) |
0.3 | 0.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 3.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 2.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 3.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.2 | 6.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 2.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 13.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 2.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.2 | 2.1 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.7 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 2.4 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 5.8 | GO:0043186 | P granule(GO:0043186) |
0.2 | 0.7 | GO:1904423 | dehydrodolichyl diphosphate synthase complex(GO:1904423) |
0.2 | 2.6 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.2 | 10.1 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 14.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 4.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 7.6 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 3.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 7.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 2.3 | GO:0033290 | eukaryotic 48S preinitiation complex(GO:0033290) |
0.1 | 2.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) prespliceosome(GO:0071010) |
0.1 | 11.5 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.1 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 13.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 7.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 6.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 8.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 13.6 | GO:0000323 | lytic vacuole(GO:0000323) |
0.1 | 4.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 1.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 2.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 4.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 2.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 9.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 14.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 3.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 87.0 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 3.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 7.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 2.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 3.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 7.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.4 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 1.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 1.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 9.6 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 4.1 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 2.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 3.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 1.9 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.1 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.0 | 4.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 1.6 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 5.2 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.0 | 0.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.8 | GO:0045174 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) |
2.0 | 8.1 | GO:0005153 | interleukin-8 receptor binding(GO:0005153) |
1.7 | 5.1 | GO:0032574 | 5'-3' RNA helicase activity(GO:0032574) |
1.3 | 6.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.3 | 5.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.2 | 6.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.2 | 3.7 | GO:0047760 | medium-chain fatty acid-CoA ligase activity(GO:0031956) butyrate-CoA ligase activity(GO:0047760) |
1.1 | 6.5 | GO:0033781 | cholesterol 24-hydroxylase activity(GO:0033781) |
1.1 | 5.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
1.1 | 7.4 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) |
1.0 | 4.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.9 | 15.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.8 | 5.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.8 | 2.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.8 | 4.1 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 2.4 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
0.8 | 5.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.8 | 4.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.8 | 3.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.8 | 3.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.8 | 2.3 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
0.8 | 10.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.7 | 3.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 6.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.7 | 6.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.7 | 2.7 | GO:0052905 | tRNA (guanine(9)-N(1))-methyltransferase activity(GO:0052905) |
0.7 | 4.6 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.6 | 3.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 3.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 10.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 3.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.6 | 10.0 | GO:0031730 | CCR1 chemokine receptor binding(GO:0031726) CCR4 chemokine receptor binding(GO:0031729) CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 1.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.5 | 1.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 6.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 2.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 2.1 | GO:1904121 | phosphatidylethanolamine transporter activity(GO:1904121) |
0.5 | 2.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.5 | 2.5 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.5 | 14.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 2.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.5 | 4.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 3.3 | GO:0045735 | nutrient reservoir activity(GO:0045735) |
0.5 | 1.9 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.5 | 14.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.5 | 8.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.5 | 3.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 6.2 | GO:0002020 | protease binding(GO:0002020) |
0.4 | 1.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.4 | 1.3 | GO:0052717 | tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 3.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 3.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 5.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 8.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 5.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 8.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 4.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 1.2 | GO:0072545 | tyrosine binding(GO:0072545) |
0.4 | 5.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 3.4 | GO:0003834 | beta-carotene 15,15'-monooxygenase activity(GO:0003834) carotenoid dioxygenase activity(GO:0010436) |
0.4 | 3.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.4 | 2.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 7.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 1.8 | GO:0016519 | gastric inhibitory peptide receptor activity(GO:0016519) |
0.4 | 6.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.4 | 2.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 3.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 7.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 2.3 | GO:0000254 | C-4 methylsterol oxidase activity(GO:0000254) |
0.3 | 1.9 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.3 | 5.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 1.2 | GO:0030586 | [methionine synthase] reductase activity(GO:0030586) |
0.3 | 3.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 2.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 5.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.3 | 7.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 1.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 3.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 1.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.2 | 3.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 2.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 2.7 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 1.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 2.1 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.2 | 5.0 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 27.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 2.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 1.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 1.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 2.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.2 | 1.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 3.8 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.8 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.6 | GO:0033819 | lipoyl(octanoyl) transferase activity(GO:0033819) |
0.2 | 1.6 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 2.0 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 1.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 1.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 3.5 | GO:0051393 | muscle alpha-actinin binding(GO:0051371) alpha-actinin binding(GO:0051393) |
0.2 | 1.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 3.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 2.1 | GO:0015929 | hyalurononglucosaminidase activity(GO:0004415) hexosaminidase activity(GO:0015929) |
0.2 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 4.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 2.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 5.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 4.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 3.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 1.4 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.2 | 7.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 3.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 29.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 3.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 2.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 3.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 2.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 9.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 3.7 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 2.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 6.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.8 | GO:0019202 | amino acid kinase activity(GO:0019202) |
0.1 | 9.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 4.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 9.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 2.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 1.1 | GO:0000048 | peptidyltransferase activity(GO:0000048) glutathione hydrolase activity(GO:0036374) |
0.1 | 10.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 2.5 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 2.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 16.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 4.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 12.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 23.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 4.0 | GO:0019956 | chemokine binding(GO:0019956) C-C chemokine binding(GO:0019957) |
0.1 | 3.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 2.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 6.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 4.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.0 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 4.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.3 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 2.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 4.7 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.1 | 4.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 4.9 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.1 | 10.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 2.3 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 1.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.1 | GO:0030623 | U5 snRNA binding(GO:0030623) |
0.1 | 1.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) dipeptide transporter activity(GO:0042936) dipeptide transmembrane transporter activity(GO:0071916) |
0.1 | 2.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 3.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 4.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 6.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 9.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 20.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 10.6 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 2.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 4.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 3.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.0 | 2.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 1.1 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 2.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 3.4 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 7.8 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 11.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 1.3 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 19.7 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.0 | 1.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0008488 | gamma-glutamyl carboxylase activity(GO:0008488) |
0.0 | 1.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 3.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 3.6 | GO:0042277 | peptide binding(GO:0042277) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.0 | 0.7 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 1.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.9 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 1.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 1.1 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 1.2 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 5.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 8.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 8.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 1.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 1.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 9.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 3.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 3.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 3.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 8.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 5.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 4.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 27.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 4.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 7.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 5.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.9 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 6.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 4.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 2.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 10.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 7.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 4.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 4.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 22.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.4 | 2.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 8.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 5.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 4.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 2.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 2.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 4.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 3.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 19.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 9.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 10.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 2.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 12.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 1.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 2.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 1.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 3.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 2.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 3.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 2.1 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 3.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 2.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 3.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 6.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 4.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 3.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 3.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 3.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 1.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 1.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 2.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.3 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |